...
首页> 外文期刊>Clinica chimica acta: International journal of clinical chemistry and applied molecular biology >Detection of hunter syndrome (mucopolysaccharidosis type II) in Taiwanese: biochemical and linkage studies of the iduronate-2-sulfatase gene defects in MPS II patients and carriers.
【24h】

Detection of hunter syndrome (mucopolysaccharidosis type II) in Taiwanese: biochemical and linkage studies of the iduronate-2-sulfatase gene defects in MPS II patients and carriers.

机译:台湾人猎人综合征(II型粘多糖贮积病)的检测:MPS II患者和携带者中的异氰酸酯-2-硫酸酯酶基因缺陷的生化和连锁研究。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Hunter syndrome (mucopolysaccharidosis type II) is an X-linked recessive lysosomal storage disease caused by a defect of the iduronate-2-sulfatase (IDS) gene. The result is impaired IDS enzyme function. METHODS: To characterize the biochemical and molecular defects in IDS-deficient patients and their families, we measured IDS enzyme activity by fluorimetric enzyme assay and identified the IDS gene mutations in 14 unrelated Taiwanese patients with varying clinical phenotypes. In addition, haplotype analysis was also performed. RESULTS: Three novel (IVS2+1G>C, 1055del12, and G489D) and 7 previously reported (N63K, P228L, K347E, R468Q, R468W, I485R, and 1241delAG) mutations were found. Together R468Q and R468W account for 42.8% mutations found in our patients. Haplotype analysis using IDS flanking markers DXS1113 and DXS1123 revealed that the unrelated R468Q alleles were independent in origin whereas the unrelated R468W alleles are probably of the same origin. The R468Q mutation in patient 1150 and I485R mutation in patient 710 occurred de novo in male meioses. Once the mutation in a family was identified, restriction analysis was also performed for rapid diagnosis of female carriers in 8 families. Leukocyte IDS measurement revealed significantly wide range of IDS activity in normal controls and MPS II carriers (19.2 - 70.6 vs. 8.4 - 26.6 nmol/h/mg cell protein). The average leukocyte IDS activity of normal controls (n=43) was 43.9+/-13.3 nmol/h/mg protein, whereas patients with MPS II (n=14) had <5% of mean normal IDS activity (0.9+/-0.6 nmol/h/mg protein), and carriers (n=13) had a mean activity of 17.5 (+/-5.7) nmol/h/mg protein. The mean leukocyte IDS activity in female carriers was less than a half of the normal level. CONCLUSION: Due to a small overlapping range of normal and carriers, the level of enzyme activity cannot be used alone for carrier detection.
机译:背景:Hunter综合征(II型粘多糖贮积病)是一种由X连锁的隐性溶酶体贮积病,它是由艾杜糖酸2-硫酸酯酶(IDS)基因的缺陷引起的。结果是IDS酶功能受损。方法:为了表征缺乏IDS的患者及其家属的生化和分子缺陷,我们通过荧光酶测定法测量了IDS酶的活性,并鉴定了14例临床表型不同的台湾无关患者的IDS基因突变。另外,还进行了单倍型分析。结果:发现了三个新的突变(IVS2 + 1G> C,1055del12和G489D)和七个先前报道的突变(N63K,P228L,K347E,R468Q,R468W,I485R和1241delAG)。 R468Q和R468W一起占我们患者中发现的42.8%突变。使用IDS侧翼标记DXS1113和DXS1123进行单倍型分析显示,不相关的R468Q等位基因在来源上是独立的,而不相关的R468W等位基因可能是相同的来源。患者1150中的R468Q突变和患者710中的I485R突变从头发生在男性中。一旦鉴定出一个家庭中的突变,就可以进行限制性分析以快速诊断8个家庭中的女性携带者。白细胞IDS测量显示正常对照和MPS II携带者中IDS活性的范围很广(19.2-70.6 vs. 8.4-26.6 nmol / h / mg细胞蛋白)。正常对照(n = 43)的平均白细胞IDS活性为43.9 +/- 13.3 nmol / h / mg蛋白,而MPS II患者(n = 14)的平均IDS活性<5%(0.9 +/-) 0.6 nmol / h / mg蛋白质)和载体(n = 13)的平均活性为17.5(+/- 5.7)nmol / h / mg蛋白质。女性携带者中平均白细胞IDS活性低于正常水平的一半。结论:由于正常和载体的重叠范围很小,因此不能单独将酶活性水平用于载体检测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号